Target expression details
Target General Information | |||||
---|---|---|---|---|---|
Target ID | T85158 | ||||
Target Name | Lymphotoxin alpha | ||||
Synonyms | LT-alpha; Lymphotoxin-alpha; TNF-beta; Tumor necrosis factor ligand superfamily member 1; LTA | ||||
Target Type | Clinical Trial | ||||
Gene Name | LTA | ||||
Biochemical Class | Cytokine: tumor necrosis factor | ||||
UniProt ID | TNFB_HUMAN | ||||
Target Gene Expression Profiles in the Disease-Relevant Drug Targeted Tissue of the Patients and Healthy Individuals | |||||
Disease | Rheumatoid arthritis | ||||
Example drug | Anti-LT alpha | Phase 2 | [1], [2] | ||
Tissue | Synovial tissue | ||||
Level of differential expression between the patients in the disease section of the tissue and the tissues of healthy individual | Fold-change: -0.19 Z-score: -0.92 P-value: 9.54E-03 |
||||
Target gene expression profiles of the patients in the disease section of the tissue
Target gene expression profiles in the tissue of healthy individual
![]() |
|||||
Target Gene Expression Profiles in Other Tissues of Healthy Individuals | |||||
![]() |
|||||
Reference | |||||
REF 1 | Clinical pipeline report, company report or official report of Genentech (2011). | ||||
REF 2 | NCBI GEO: archive for functional genomics data sets--update. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.